您的位置: 首页 > 农业专利 > 详情页

Heterocyclic compound
专利权人:
Takeda Pharmaceutical Company Limited
发明人:
KAMATA, Makoto,SUGIYAMA, Hideyuki,NAKAMURA, Minoru,MURAKAMI, Masataka,IKEDA, Shuhei,OKAWA, Tomohiro,TOKUHARA, Hidekazu
申请号:
AU2018338855
公开号:
AU2018338855A1
申请日:
2018.09.27
申请国别(地区):
AU
年份:
2020
代理人:
摘要:
Provided is a compound which has an MAGL inhibitory effect and is expected to be useful as a prophylactic or therapeutic agent for neurodegenerative diseases (e.g., Alzheimer's disease, Parkinson's disease, Hutchinson's disease, amyotrophic lateral sclerosis, traumatic brain injury, glaucoma, multiple sclerosis, etc.), anxiety disorders, pains (e.g., inflammatory pain, cancer pain, neuropathic pain, etc.), epilepsy, depression and the like. The present invention pertains to a compound represented by formula (I): [wherein each symbol is as described in the description] or a salt thereof.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充